- Report
- November 2025
- 150 Pages
Global
From €4377EUR$4,850USD£3,803GBP
- Report
- September 2025
- 150 Pages
Global
From €4377EUR$4,850USD£3,803GBP
- Report
- December 2025
- 137 Pages
Global
From €4377EUR$4,850USD£3,803GBP
- Report
- November 2025
- 142 Pages
Global
From €4377EUR$4,850USD£3,803GBP
- Report
- May 2025
- 119 Pages
Global
From €2662EUR$2,950USD£2,313GBP
- Report
- June 2025
- 120 Pages
United States
From €5370EUR$5,950USD£4,665GBP
- Report
- February 2026
- 75 Pages
Europe
From €2933EUR$3,250USD£2,548GBP
- Report
- February 2026
- 68 Pages
Asia Pacific
From €2933EUR$3,250USD£2,548GBP
- Report
- February 2026
- 57 Pages
Asia Pacific
From €2933EUR$3,250USD£2,548GBP
- Report
- February 2026
- 70 Pages
Europe
From €2933EUR$3,250USD£2,548GBP
- Report
- April 2025
- 163 Pages
Asia Pacific
From €3113EUR$3,450USD£2,705GBP
- Report
- September 2025
- 99 Pages
United States
From €4377EUR$4,850USD£3,803GBP
- Report
- April 2022
- 400 Pages
Global
€1579EUR$1,750USD£1,372GBP
- Report
- December 2022
- 437 Pages
Global
From €4706EUR$5,397USD£3,950GBP
- Report
- March 2025
- 407 Pages
Global
From €4331EUR$4,799USD£3,763GBP
- Report
- September 2022
- 799 Pages
Global
From €4331EUR$4,799USD£3,763GBP
- Report
- April 2019
- 850 Pages
Global
From €4060EUR$4,499USD£3,527GBP
- Report
- May 2024
- 224 Pages
Global
From €4331EUR$4,799USD£3,763GBP
- Report
- January 2019
- 230 Pages
Global
From €3609EUR$3,999USD£3,135GBP
- Report
- March 2025
- 84 Pages
Global
From €400EUR$475USD£360GBP

Prodrugs are a type of biotechnology that involves the modification of a drug molecule to improve its pharmacokinetic properties. This is done by making the drug more soluble, increasing its absorption, or making it more stable in the body. Prodrugs are designed to be more effective and safer than the original drug, and can be used to treat a variety of diseases.
Prodrugs are used in a variety of therapeutic areas, including cancer, cardiovascular disease, and infectious diseases. They are also used to improve the delivery of drugs to specific tissues or organs, and to reduce the side effects of drugs.
The prodrug market is growing rapidly, driven by the increasing demand for more effective and safer drugs. The market is expected to continue to grow in the coming years, as more companies develop and launch new prodrugs.
Some companies in the prodrug market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more